Levetiracetam A.Forall

Levetiracetam, the active ingredient in Levetiracetam A.Forall, is a Anticonvulsant presented as a intravenous solution for intravenous use. It treats partial‑onset seizures, generalized tonic‑clonic seizures and myoclonic seizures in patients requiring acute management.

GNH USA supplies Levetiracetam A.Forall as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic medication used to control various seizure types.

- Partial‑onset seizures: reduces frequency and severity of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: decreases rapid muscle jerks associated with epilepsy.

Levetiracetam may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: sensation of lightheadedness or unsteadiness. - Headache: mild to moderate cranial pain. - Nausea: feeling of stomach discomfort or urge to vomit.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or breathing difficulty. - Mood changes: depression, anxiety, or suicidal thoughts. - Blood abnormalities: low platelet count or neutropenia.

When using levetiracetam, certain precautions should be observed to ensure safety and efficacy. - Renal function: assess kidney function and adjust therapy if impairment is present. - Concomitant CNS depressants: monitor for enhanced sedation when combined with other central nervous system depressants. - Pregnancy: discuss potential risks with a healthcare provider as safety data are limited. - Psychiatric history: observe patients with prior mood disorders for behavioral changes. - Storage: Store at room temperature: keep in original container, protect from light and moisture.

Levetiracetam can interact with other medicines, affecting its concentration or therapeutic effect.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels, decreasing efficacy. - Phenobarbital: can lower levetiracetam concentrations, potentially compromising seizure control.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam levels, requiring monitoring for side effects. - Opioids: concurrent use may enhance central nervous system depression. - Antidepressants: monitor for increased risk of mood alterations.